Thousand Oaks, CA, United States of America

Lei-Ting Tony Tam

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Amgen Inc., Atara Biotherapeutics, Inc.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei-Ting Tony Tam. Retrieved from https://idiyas.com/inventor/lei-ting-tony-tam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 92.3

 

 

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 308(Granted Patents)


Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Inventor Lei-Ting Tony Tam

Introduction:

Lei-Ting Tony Tam is a renowned inventor based in Thousand Oaks, CA. He is known for his groundbreaking innovations in various fields.

Latest Patents:

Lei-Ting Tony Tam holds several patents in the areas of technology and healthcare, showcasing his diverse range of expertise and creativity.

Career Highlights:

Throughout his career, Lei-Ting Tony Tam has consistently pushed the boundaries of innovation, with his inventions making a significant impact in the industry. His dedication to creating solutions for complex problems has earned him recognition worldwide.

Collaborations:

Lei-Ting Tony Tam has collaborated with leading companies and research institutions to further develop his inventions and bring them to the market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

Inventor Lei-Ting Tony Tam's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary in the field. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…